01OverviewDefinition, clinical context and the essential points that orientate the chapter.
Developmental delay is slower acquisition of expected functional skills compared with peers. Global developmental delay is used in children under 5 when at least two domains are significantly affected; intellectual disability is assessed later through both intellectual and adaptive functioning. A mild variation, developmental difference and clinically significant delay are separated by trajectory, function, standardised assessment and context rather than one milestone.
Map each domain separately. Gross motor includes posture and mobility; fine motor includes hand use and visual-motor integration; language includes receptive, expressive and pragmatic communication; cognition includes learning and problem-solving; social-emotional function includes reciprocity and regulation; adaptive skills include feeding, dressing, toileting and safety. Dissociation between domains can be diagnostically useful, while global delay suggests a more widespread process.
History starts before conception. Ask about parental health and learning, consanguinity and similarly affected relatives; pregnancy infection, medication, alcohol or drug exposure; fetal growth; gestation, delivery, encephalopathy, neonatal seizures and screening; feeding and growth; serious infection, trauma and seizures; chronic illness and medicines. Construct a three-generation family history and ask about pregnancy losses and adult neurological disease when a genomic cause is possible.
Describe developmental onset and course. Establish which skills are secure, emerging or absent, how the child communicates needs and whether function differs across settings. Correct for prematurity early in life. Ask about any loss, plateau, episodic decline, fatigue or worsening during illness. Obtain nursery or school information and review opportunities to hear, see, move, play and interact in every language used.
Examination includes accurate weight, length or height and head circumference plotted serially; dysmorphism and skin; vision and hearing behaviour; cardiac, abdominal and musculoskeletal examination; and a full neurological assessment of cranial nerves, tone, power, reflexes, movement, coordination, gait and symmetry. Note congenital anomalies, organomegaly, neurocutaneous marks and body proportions. Photographs for dysmorphology require appropriate consent and secure handling.
Isolated gross-motor delay can reflect normal variation, cerebral palsy, muscular dystrophy, congenital myopathy, spinal or orthopaedic disease, hypothyroidism or limited opportunity. NICE recommends child-development referral when sitting or walking thresholds are missed or hand function is asymmetric, and CK consideration in boys. Physiotherapy and occupational therapy should not wait for a complete diagnosis.
Isolated speech or language delay may reflect hearing loss, developmental language disorder, speech-sound disorder, autism, intellectual disability or a limited assessment in the child's weaker language. Formal audiology is essential because newborn screening does not exclude acquired or progressive loss. Receptive difficulty, loss of language, poor gesture or joint attention and broader adaptive problems increase concern beyond isolated expressive delay.
Global delay may arise from chromosomal or single-gene disorders, brain malformation, prenatal or perinatal injury, infection, cerebral palsy, neurometabolic disease, endocrine or nutritional disease and severe environmental adversity. Sometimes no cause is identified. Aetiology can clarify recurrence risk, surveillance and treatment, but investigation must not make support conditional on receiving a molecular diagnosis.
First-line tests are phenotype guided. Formal hearing and vision testing and a standardised developmental profile have high immediate value. Common blood tests may include FBC, ferritin, U&E, liver and bone profile, thyroid function, CK and coeliac serology when history or examination supports them. Test lead only with exposure risk and use ammonia, lactate, plasma amino acids, acylcarnitine or urine organic acids when regression, episodic illness, organomegaly, movement disorder or another metabolic clue is present.
In England, genomic testing should follow the current National Genomic Test Directory. Moderate-to-profound unexplained developmental delay or intellectual disability, congenital anomalies, dysmorphism and a suggestive family history can meet specific pathways; isolated autism or mild intellectual disability alone may not. Record detailed phenotype and Human Phenotype Ontology terms, obtain informed consent and involve clinical genetics or the Genomic Laboratory Hub as the pathway requires.
MRI brain is most useful with abnormal head size or trajectory, focal neurology, seizures, regression, cerebral palsy of unclear cause or suspected structural abnormality. It may require sedation or anaesthesia, so ask a specific question. EEG supports evaluation of suspected seizures or epileptic encephalopathy but cannot exclude epilepsy when normal. Sleep EEG can be crucial when regression or school deterioration suggests sleep-activated epileptiform activity.
Management starts with the child's current barriers. Physiotherapy addresses posture and mobility, occupational therapy hand and adaptive function, speech and language therapy communication and eating, and audiology or ophthalmology sensory access. Use augmentative and alternative communication early when speech is limited. Review nutrition, sleep, constipation, pain and behaviour because untreated discomfort can suppress participation.
Coordinate health, education and social care around one profile and named lead. Provide accessible information, genomic counselling when relevant, carer support and an emergency plan for epilepsy or metabolic risk. Review safeguarding without equating disability with neglect and involve the child through their preferred communication.
Key points
- Global developmental delay means significant delay in at least two domains in a child younger than 5; isolated delay predominantly affects one domain.
- Describe the profile and function before seeking an aetiological label: gross motor, fine motor or vision, speech and language, cognition or play, social-emotional and adaptive skills.
- Use exact and corrected age, serial acquisition and real-world examples from caregivers and nursery or school; one clinic performance is insufficient.
- First-line assessment is a comprehensive developmental, medical, birth, family and social history plus growth, dysmorphology, neurological, hearing and vision assessment.
- Support strong parental concern even when a screening questionnaire is reassuring; developmental tools structure assessment but do not exclude pathology.
- Isolated motor delay prompts examination of tone, power, reflexes, symmetry and CK consideration in boys; isolated language delay always prompts hearing assessment.
- Global delay has a broad differential including genomic disorders, prenatal exposure, brain malformation or injury, cerebral palsy, sensory loss, endocrine and metabolic disease and severe psychosocial adversity.
- Genomic testing follows the current NHS National Genomic Test Directory phenotype and eligibility criteria, with consent and clinical-genetics support where needed.
- Routine blanket MRI, EEG or metabolic panels are not appropriate for every child; abnormal neurology, head size, seizures, regression or metabolic features increase yield.
- A normal EEG cannot exclude epilepsy, and EEG is not a general test for developmental delay without episodes or regression suggesting epileptic activity.
- Management is needs led: therapy, communication support, hearing or vision correction, nutrition, education and family support begin before the cause is finalised.
- Reassess the diagnostic formulation over time because an apparently isolated delay may become multidomain as developmental demands increase.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
Genomic and congenital causes
Chromosomal, copy-number, single-gene and imprinting disorders, brain malformations and congenital anomalies can affect several domains and produce dysmorphism, abnormal growth or organ-specific risks.
Prenatal and perinatal injury
Infection, teratogen exposure, extreme prematurity, hypoxic-ischaemic injury, stroke and neonatal complications can disrupt developing brain networks and motor function.
Acquired medical causes
CNS infection, trauma, epilepsy, severe malnutrition, hypothyroidism, lead exposure and neurometabolic or neurodegenerative disorders may slow, distort or reverse development.
Sensory and environmental constraints
Hearing or vision loss, severe psychosocial adversity and restricted opportunity can impair observed acquisition, while also coexisting with biological neurodevelopmental conditions.
03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
- 1Altered neural development
Genetic, structural or prenatal insults change neuronal proliferation, migration, synaptic organisation and network connectivity, producing domain-specific or global functional differences.
- 2Motor-system injury
Damage to corticospinal, basal-ganglia, cerebellar, peripheral nerve or muscle pathways changes tone, selective control, strength and the opportunity to explore and learn.
- 3Reduced sensory input
Hearing and visual impairment limit language mapping, joint attention, balance and visual-motor learning during sensitive developmental periods unless access is restored.
- 4Progressive neuronal dysfunction
Metabolic, degenerative or epileptic encephalopathies impair established networks over time, causing plateau or loss rather than a purely late acquisition pattern.
04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Mobility or hand skill lags while language and social learning are stronger, directing neurological, neuromuscular and orthopaedic examination.
Speech, expressive or receptive language is predominantly affected, requiring formal hearing and social-communication assessment in all languages.
At least two domains are significantly affected in a child under 5, often with adaptive difficulty and a broad aetiological differential.
Uneven strengths and needs, such as strong social understanding with severe motor impairment, helps localise the principal constraint.
Delay with dysmorphism, congenital anomalies, abnormal growth, organ disease or family history increases the likelihood of a genomic diagnosis.
Loss, fluctuating encephalopathy or illness-triggered deterioration indicates neurological, epileptic or metabolic assessment rather than routine developmental surveillance.
05InvestigationsWhat to request, why it matters and how to interpret it.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
First-line: standardised developmental and adaptive assessmentFirst stepFirst line - Why
- Define which domains are delayed, severity, strengths and functional support needs.
- Interpretation and limitations
- Use corrected age and culturally and linguistically appropriate tools; scores complement direct observation and real-world reports.
- 02
First-line: formal hearing and vision assessmentFirst line - Why
- Detect sensory impairment causing or compounding delay.
- Interpretation and limitations
- Use age- and development-appropriate audiology and ophthalmology; prior newborn screening or casual response does not exclude impairment.
- 03
First-line: phenotype-led medical evaluationFirst line - Why
- Identify growth, neurological, dysmorphic, systemic and environmental clues that determine further tests.
- Interpretation and limitations
- Plot head and body growth, perform neurological and systemic examination and create a three-generation family history.
- 04
Targeted laboratory screen - Why
- Detect treatable haematological, nutritional, thyroid, coeliac, renal, hepatic or neuromuscular contributors.
- Interpretation and limitations
- Select from FBC, ferritin, U&E, LFT, bone profile, TSH, free T4, coeliac serology and CK according to profile; indiscriminate panels create false positives.
- 05
NHS genomic testing pathway - Why
- Identify a chromosomal or monogenic diagnosis that changes surveillance, treatment or recurrence counselling.
- Interpretation and limitations
- Apply the latest National Genomic Test Directory eligibility and phenotype requirements; testing type is selected by the genomic pathway, not a fixed universal panel.
- 06
Specialist MRI, EEG or metabolic testing - Why
- Investigate structural, epileptic or biochemical disease when clinical features raise pre-test probability.
- Interpretation and limitations
- MRI is targeted to neurological signs; EEG supports but does not exclude epilepsy; metabolic sampling may be time-sensitive during decompensation.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
Normal developmental variation
A later skill with continued acquisition, normal quality and reassuring other domains may lie within variation, but needs a defined review rather than indefinite reassurance.
Sensory impairment
Hearing or vision loss can present as language, social, motor or learning difficulty and requires formal testing regardless of newborn screening history.
Autism or language disorder
Reciprocal social-communication and restricted-behaviour patterns suggest autism, while a more circumscribed speech or language profile may indicate developmental language disorder.
Cerebral palsy or neuromuscular disease
Abnormal tone, asymmetry, persistent reflexes, weakness, Gowers sign or loss of endurance distinguishes motor pathology from general late walking.
Global intellectual or genomic disorder
Multidomain and adaptive impairment with dysmorphism, abnormal growth, congenital anomalies or family history supports community paediatric and genomic assessment.
07ManagementImmediate care, first-line treatment, alternatives and escalation.
01ProfileDefine delay before testingFirst stepA caregiver, health visitor, nursery or clinician raises developmental concern.+
- 1Map every domain, adaptive function, acquisition and any loss using exact and corrected age and reports from more than one setting.
- 2Plot growth and head circumference and complete sensory, neurological, dysmorphology and systemic assessment.
- 3Classify provisionally as isolated, global, dissociated, deviated or regressive and refer at defined motor or speech thresholds.
02Isolated delayTest the domain and its accessOne domain is substantially weaker than the others.+
- 1For language, arrange audiology and speech-language assessment; for motor delay, examine tone, power, symmetry and consider CK in boys.
- 2Begin domain-specific therapy and environmental adjustments immediately.
- 3EscalationReview all domains over time and escalate if another domain, regression or abnormal examination emerges.
03Global delayCoordinate cause and needs assessmentTwo or more developmental domains and adaptive function are significantly affected.+
- 1Refer to community paediatrics and complete formal hearing, vision and developmental assessment.
- 2Use phenotype to select laboratory, genomic, imaging, EEG and metabolic investigations under current pathways.
- 3Appoint coordinated therapy, education, communication and family support with a shared review plan.
04Regression or seizuresEscalate neurological investigationEscalationSkills are lost, episodes occur or behaviour and learning deteriorate unexpectedly.+
- 1Assess acuity, glucose, infection, toxin, trauma and seizure features and obtain videos or eyewitness detail when safe.
- 2Refer promptly to paediatric neurology; suspected infantile spasms require tertiary advice within 24 hours and sleep EEG.
- 3Use MRI, EEG and metabolic or genomic testing according to the specialist differential while protecting function and safety.
05Long-term supportReview function and family capacityDelay persists with or without an identified diagnosis.+
- 1Set measurable communication, mobility, self-care, education and participation goals with the child and family.
- 2Monitor sensory health, growth, feeding, sleep, pain, seizures, equipment and coexisting mental health or behaviour.
- 3Review safeguarding, respite, benefits, carer support and transition ownership as needs evolve.
08ComplicationsImportant consequences, why they occur and why they matter clinically.
Communication and participation restriction
Unmet speech, motor or sensory needs can limit relationships, education, autonomy and access to healthcare even when the underlying condition is stable.
Feeding and physical-health problems
Oromotor dysfunction, aspiration, constipation, sleep disorder, immobility and poor growth may compound development and require active surveillance.
Epilepsy and behavioural distress
Seizures, pain, anxiety, frustration and communication barriers can present as challenging behaviour and worsen learning when unrecognised.
Family and safeguarding burden
High care needs, fragmented services, financial pressure and reduced respite increase family stress, while disabled children remain at increased risk of abuse and neglect.
09Monitoring and follow-upTreatment response, safety checks and longer-term review.
- Track new skills and functional participation with the same developmental framework rather than repeating only a diagnostic label.
- Ask explicitly about loss, seizures, unusual movements, fatigue and illness-triggered decline at each review.
- Repeat hearing and vision assessment when behaviour changes or risk factors exist; sensory loss can be progressive or fluctuating.
- Plot weight, height and head circumference and monitor feeding safety, constipation, sleep and pain because these alter development and wellbeing.
- Review therapy access, equipment, communication systems and educational adjustments and name who is responsible for each action.
- Revisit genomic eligibility and phenotype as the child develops; a later-emerging feature can make a previously non-diagnostic test strategy obsolete.
10Special situationsVariants, exceptions and circumstances that change the usual approach.
Profile before label
Knowing how a child moves, understands, communicates and manages daily life is more actionable than recording delay without domains.
Sensory access is foundational
Hearing or vision impairment can mimic broader delay and also coexist with neurological or genomic disorders.
A cause can change care
Aetiological diagnosis may trigger cardiac, renal, seizure or tumour surveillance and give the family meaningful recurrence information.
Testing follows phenotype
MRI, EEG, metabolic and genomic tests have higher yield when selected from examination, course and family history rather than ordered uniformly.
11Common pitfallsFrequent interpretation and management errors.
- 01
Do not describe delay without identifying affected and preserved domains.
- 02
Do not use a screening questionnaire as a diagnostic or exclusion test.
- 03
Do not assume an isolated speech delay before formal hearing assessment.
- 04
Do not attribute motor delay to temperament without tone, power and symmetry examination.
- 05
Do not order MRI, EEG and metabolic panels indiscriminately in every child.
- 06
Do not use a normal EEG to exclude epilepsy.
- 07
Do not request outdated genomic tests without checking the current National Genomic Test Directory pathway.
- 08
Do not wait for an aetiological diagnosis before starting therapy or communication support.
- 09
Do not explain poor care or missed appointments solely by disability without assessing safeguarding and access barriers.
- 10
Do not call loss of skills a developmental plateau.